Published on 7 May 2024 on Zacks via Yahoo Finance
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Misses Revenue Estimates
Rhythm Pharmaceuticals, Inc. (RYTM) came out with a quarterly loss of $2.35 per share versus the Zacks Consensus Estimate of a loss of $2.34. This compares to loss of $0.92 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -0.43%. A quarter ago, it was expected that this company would post a loss of $0.70 per share when it actually produced a loss of $0.70, delivering no surprise.